2007年南京地区22家医院抗感染药物利用分析  

Utilization of antibiotics in 22 hospitals in Nanjing city during 2007

作　　者：张吉[1] 邹颖[1] 冯琳[1] 戴惠珍[2] 

机构地区：[1]南京医科大学第一附属医院,南京210029 [2]江苏省医药情报研究所,南京210004

出　　处：《中国新药杂志》2010年第3期258-261,共4页Chinese Journal of New Drugs

摘　　要：目的:评价2007年南京地区抗感染药物应用状况。方法:应用金额排序法和用药频度排序法,对22家入网医院2007年临床使用的抗感染药物进行统计和分析。结果:2007年抗感染药物用药总额为6.8亿元,其中β-内酰胺类药物及喹诺酮类药物占市场份额的一半以上。位于DDDs排序前列的主要为左旋氧氟沙星、罗红霉素及阿莫西林。结论:2007年南京地区抗感染药物各品种使用基本规范,但仍应加强对于β-内酰胺类、喹诺酮类及大环内酯类等使用广泛的抗感染药物的管理,以提高药物疗效,减少耐药性。Objective：To evaluate the utilization tendency of antibiotics in 22 hospitals in Nanjing city. Methods：The use of antibiotics agent in 22 hospitals in Nanjing during 2007 was statistically analyzed in terms of drug varieties,consumption and DDDs. Results：The consumption sum of β-laetam antibiotics was 6.8 hundred million Yuan. The β-lactam antibiotics and quinolones accounted for more than half of the market share. The forefront of DDDs ranking was mainly levofloxacin, roxithromyein and amoxieillin. Conclusion：The consumption sum and DDDs ranking of antibiotics in Nanjing city during 2007 were stable and normal;however, the use of antibiotics should be further monitored for rational use of antibiotics.

关 键 词：抗感染药物 药物利用 南京地区 

分 类 号：R978[医药卫生—药品] R969.3[医药卫生—药学]